CVR number 39676303
Industry 75.0000 Veterinary activities

Dyrenes Læge og Øjenklinik ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  3.7% 4.0% 4.7% 3.2% 3.4%  
Credit score (0-100)  51 48 45 54 54  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  1,331 2,125 2,587 2,593 2,689  
EBITDA  669 1,085 1,603 1,704 1,137  
EBIT  595 966 1,431 1,534 966  
Pre-tax profit (PTP)  589.5 957.7 1,436.9 1,578.2 1,023.8  
Net earnings  458.0 744.8 1,116.7 1,228.7 795.0  
Pre-tax profit without non-rec. items  590 958 1,437 1,578 1,024  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  546 1,130 1,129 958 789  
Shareholders equity total  1,108 1,553 2,169 2,898 2,693  
Interest-bearing liabilities  6.7 29.2 0.0 0.5 0.0  
Balance sheet total (assets)  1,630 2,274 2,858 3,749 3,363  
Net Debt  -941 -893 -715 -1,397 -1,973  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,331 2,125 2,587 2,593 2,689  
Gross profit growth  8.3% 59.7% 21.7% 0.2% 3.7%  
Employees  1 2 2 1 2  
Employee growth %  0.0% 100.0% 0.0% -50.0% 100.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,630 2,274 2,858 3,749 3,363  
Balance sheet change%  40.4% 39.5% 25.7% 31.2% -10.3%  
Added value  668.7 1,085.3 1,603.4 1,706.3 1,137.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  141 464 -174 -341 -340  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  44.7% 45.4% 55.3% 59.2% 35.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  42.6% 49.5% 56.2% 47.8% 28.8%  
ROI %  57.0% 71.4% 76.9% 62.3% 36.6%  
ROE %  44.5% 56.0% 60.0% 48.5% 28.4%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  68.0% 68.3% 75.9% 77.3% 80.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -140.7% -82.3% -44.6% -81.9% -173.5%  
Gearing %  0.6% 1.9% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  71.6% 44.5% 41.1% 0.0% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  2.1 1.5 2.5 3.2 3.8  
Current Ratio  2.1 1.6 2.5 3.3 3.8  
Cash and cash equivalent  947.3 922.2 715.1 1,397.3 1,972.7  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  570.0 422.3 1,040.5 1,939.9 1,903.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  669 543 802 1,706 569  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  669 543 802 1,704 569  
EBIT / employee  595 483 715 1,534 483  
Net earnings / employee  458 372 558 1,229 397